Cite

HARVARD Citation

    Wong, J. et al. (n.d.). DOP50 Oral α4β7 integrin inhibitor MORF-057 demonstrates exposure driven biomarker response in non-human primates. Journal of Crohn's and colitis. pp. i098-i099. [Online]. 
  
Back to record